Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Analog Devices, Inc. (ADI) vs Church & Dwight Co., Inc. (CHD) Price & Performance

Analog Devices, Inc.Trade
Church & Dwight Co., Inc.Trade

Price performance (Past 24H)

Key statistics

Analog Devices, Inc. vs Church & Dwight Co., Inc. — how do they compare? Analog Devices, Inc. trades at $387.66 (market cap $187.00B), while Church & Dwight Co., Inc. trades at $102.84 (market cap $24.50B). The key difference: Analog Devices, Inc. is far larger — about 7.6× Church & Dwight Co., Inc.'s market cap, and Church & Dwight Co., Inc. pays the higher dividend (1.19%). Which is the better fit depends on your goals.

ADICHD
Market Cap
$187.00B$24.50B
Sector
TechnologyConsumer Staples
52-Week High
$445.48$105.26
52-Week Low
$224.12$81.60
Enterprise Value
$192.25B$26.50B
Dividend Yield
1.15%1.19%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Analog Devices, Inc.

Analog Devices (ADI) trades at $389.93, up 3.34% over the past day, with a bullish technical signal and strong institutional support. The stock has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.09 exceeding expectations. Revenue for 2025 reached $11.02 billion, with a net income margin of 26.01%, though valuation ratios like P/E of 58.03 suggest premium pricing. A dividend of $1.10 per share is scheduled for payment on June 16, 2026.

The outlook for ADI is positive, driven by robust earnings performance and analyst optimism, with a consensus price target of $474.80 implying significant upside. Risks include high valuation multiples and sensitivity to semiconductor market cycles, but strong cash flow and institutional buy-in support a favorable investment case for growth-oriented investors.

Church & Dwight Co., Inc.

Church & Dwight (CHD) trades at $103.24, slightly below the consensus price target of $103.57, with a modest 24-hour decline of 0.12%. The stock exhibits a bullish technical trend, supported by moving averages, while fundamentals show steady revenue growth to $6.20 billion in 2025 and a net income margin of 11.96%. Recent Q2 2026 earnings matched estimates with organic sales growth of 5.8%, prompting raised full-year guidance. Analyst sentiment is positive with 53% buy ratings, though valuation multiples like a P/E of 33.09 suggest premium pricing.

The outlook remains favorable due to strong brand performance and raised earnings guidance, but risks include elevated debt levels and competitive pressures in consumer staples. Institutional activity shows mixed positions, with some funds reducing stakes. The stock's upside is capped by high valuations, requiring sustained earnings growth to justify current levels.

Returns comparison

Trailing returns across standard periods

About Analog Devices, Inc.

Analog Devices is a leading analog, mixed signal, and digital signal processing chipmaker. The firm has a significant market share lead in converter chips, which are used to translate analog signals to digital and vice versa. The company serves tens of thousands of customers, and more than half of its chip sales are made to industrial and automotive end markets. Analog Devices' chips are also incorporated into wireless infrastructure equipment.

Read more on ADI

About Church & Dwight Co., Inc.

Church & Dwight is the leading producer of baking soda in the world. Beyond baking soda, the products in its portfolio have vast category reach, including laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its mix also includes Xtra, Trojan, OxiClean, First Response, Nair, L'il Critters/Vitafusion, Orajel, and WaterPik, which together with Arm & Hammer constitute more than 80% of its annual sales and profits. In early 2019, the firm announced the addition of Flawless, which manufactures electric shaving products for women. At the end of 2020, the firm acquired Zicam, a leading brand in the cough/cold-shortening category. Church & Dwight derives more than 80% of its sales from its home market in the U.S.

Read more on CHD